Suppr超能文献

内镜下套扎术与肾上腺素注射治疗活动性马洛里-魏斯综合征的前瞻性随机试验。

A prospective, randomized trial of endoscopic band ligation vs. epinephrine injection for actively bleeding Mallory-Weiss syndrome.

作者信息

Park Chang-Hwan, Min Sang-Woon, Sohn Young-Hae, Lee Wan-Sik, Joo Young-Eun, Kim Hyun-Soo, Choi Sung-Kyu, Rew Jong-Sun, Kim Sei-Jong

机构信息

Department of Internal Medicine, Division of Gastroenterology, Chonnam National University Medical School, Gwangju, Korea.

出版信息

Gastrointest Endosc. 2004 Jul;60(1):22-7. doi: 10.1016/s0016-5107(04)01284-2.

Abstract

BACKGROUND

Effective hemostatic treatment is mandatory for patients with actively bleeding Mallory-Weiss syndrome. This study evaluated the respective efficacy and the safety of endoscopic band ligation and endoscopic epinephrine injection in Mallory-Weiss syndrome.

METHODS

Thirty-four consecutive patients with actively bleeding Mallory-Weiss syndrome were prospectively enrolled and were randomly assigned to undergo endoscopic band ligation or endoscopic injections of a 1:10,000 solution of epinephrine. Demographic characteristics, endoscopic variables, and outcome parameters, including rates of hemostasis and recurrent bleeding, were analyzed.

RESULTS

The number of elastic bands applied was one or two; the mean volume of epinephrine injected was 18.0 mL: 95% CI[16.8, 19.2]. There was no significant difference between the groups with respect to age, gender, alcohol ingestion, presenting symptoms, Hb level, shock, comorbid diseases, coagulopathy, tear location, blood transfusion, or duration of hospitalization. Primary hemostasis was achieved in all 17 patients in the band ligation group and in 16 of 17 patients (94.1%) in the epinephrine injection group. There was no recurrence of bleeding or major complication in either group.

CONCLUSIONS

In this small study, no difference was detected in the efficacy or the safety of band ligation vs. epinephrine injection for the treatment of actively bleeding Mallory-Weiss syndrome.

摘要

背景

对于活动性出血的马洛里-魏斯综合征患者,有效的止血治疗是必不可少的。本研究评估了内镜下套扎术和内镜下肾上腺素注射术治疗马洛里-魏斯综合征的疗效和安全性。

方法

前瞻性纳入34例连续性活动性出血的马洛里-魏斯综合征患者,并随机分配接受内镜下套扎术或内镜下注射1:10000肾上腺素溶液。分析人口统计学特征、内镜变量和结局参数,包括止血率和再出血率。

结果

应用的弹性圈数量为1个或2个;肾上腺素的平均注射量为18.0 mL:95%置信区间[16.8, 19.2]。两组在年龄、性别、饮酒情况、出现的症状、血红蛋白水平、休克、合并疾病、凝血障碍、撕裂部位、输血或住院时间方面无显著差异。套扎术组的17例患者和肾上腺素注射组的17例患者中的16例(94.1%)实现了初步止血。两组均未出现再出血或严重并发症。

结论

在这项小型研究中,对于治疗活动性出血的马洛里-魏斯综合征,套扎术与肾上腺素注射术在疗效或安全性方面未发现差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验